Anne H. Cross, MD, is the Manny and Rosalyn Rosenthal - Dr. John Trotter MS Center Chair in Neuroimmunology and Professor of Neurology at Washington University School of Medicine in St. Louis. She received her medical degree from the University of Alabama School of Medicine and completed her neurology residency training at George Washington University, serving as Chief Resident in her final year. Following six years of fellowship training in the Neuroimmunology Branch at the National Institutes of Health, Saint Jude Children's Research Hospital and Albert Einstein College of Medicine, Dr. Cross was awarded the Harry Weaver Neuroscience Scholar Award from the National Multiple Sclerosis Society. Her research interests include understanding the mechanisms involved in pathogenesis of inflammation and demyelination in the central nervous system (brain and spinal cord). Dr. Cross has authored or coauthored several peer-reviewed journal articles that have been published in Archives of Neurology, American Journal of Pathology, and Journal of Leukocyte Biology, amongst others. She is a member of the American Academy of Neurology, International Society of Neuroimmunology, Central Society for Neurologic Research and the American Neurological Association.  

Benjamin M. Segal, MD, is the Holtom-Garrett Professor of Neurology, and Director of the Multiple Sclerosis Center and Program in Neuroimmunology at the University of Michigan. He is also a Senior Scholar of the A. Alfred Taubman Medical Research Institute and Chair of the Scientific Advisory Board, VA Multiple Sclerosis Centers of Excellence-East. Dr. Segal received his BS in Biochemistry, magna cum laude (’84), and his MD (’88) with honors from Brown University. He took an internship in Internal Medicine at the University of Chicago and a residency in Neurology at the New York Hospital/Cornell University Medical School. He then did fellowships in Neuroimmunology at NINDS, NIH and  Cellular Immunology at NIAID, NIH.  He was a Lieutenant Commander in the Public Health Service between 1992-1999. Dr. Segal’s research interests include the role of cytokine/chemokine networks in MS and its animal models, and the discovery of biomarkers and novel therapeutic targets in MS.  His awards include the Harry Weaver Neuroscience Award from the National Multiple Sclerosis Society, Commendation Medal from the Public Health Service and a Taubman Scholar Award.  He has been consistently named to the “Best Doctors in America” list since 2011.  In 2014, he was inducted into the University of Michigan League of Research Excellence.  He is currently Chair of the Research Advisory Board for the VA Multiple Sclerosis Centers of Excellence-East and Chair of the Program Committee for the Americas Committee for Research & Treatment in Multiple Sclerosis (ACTRIMS).

Jack Antel is a clinical neurologist who coordinates the Multiple Sclerosis Research and Treatment Program at the Montreal Neurological Institute. He serves as the Scientific Director of the endMS Research and Training Network supported by the MS Society of Canada. He has been President of the International Society of Neuroimmunology, is president-elect of ACTRIMS, and is co-Editor of the Multiple Sclerosis Journal.  His research interests include understanding the mechanisms of tissue injury and repair that occur in MS and how these can be therapeutically targeted. He received the 2005 Dystel Award from the National Multiple Sclerosis Society and the American Academy of Neurology.